[ 9 ] Wurst KE, Ephross SA, Loehr J, et al. Evaluation of the Gengeal Practice Reseaech Datdbase congenital heart defects prevalence: comparison to United Kingdom national systems[J]. Brith Defects Res A Clin Mol Teratol, 2007, 79(4): 309-316.
[5]
DeGroff CG, BhatikarS, Hertzberg J, et al. Artificial neural network？based method of screening heart murmurs in children[J]. Circulation, 2001, 103(22): 2711-2716.
[6]
D’Alto M, Mahadevan VS. Pulmonary arterial hypertension associated with congenital heart disease[J]. Eur Respir Rev, 2012, 21(126): 328-337.
[7]
Okubo A, Miyoshi O, Baba K, et al. A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family[J]. J Med Genet, 2004, 41(7): e97.
[8]
Baardman ME, Kerstjens-Frederikse WS, Corpeleijn E, et al. Combined adverse effects of maternal smoking and high body mass index on heart development in offspring: evidence for interaction[J]. Heart, 2012, 98(6): 474-479.
[9]
Khairy P, Ouyang DW, Fernandes SM, et al. Pregnancy outcomes in women with congenital heart disease[J]. Circulation, 2006, 113(4): 517-524.
[10]
Marelli AJ, Mackie AS, Ionescu-Ittu R, et al. Congenital heart disease in the general population: changing prevalence and age distribution[J]. Circulation, 2007, 115(2): 163-172.
[11]
Olsen M, Videb？k J, Johnsen SP, et al. The Danish register of congenital heart disease[J]. Scand J Public Health, 2011, 39(7 ): 50-53.
[ 7 ] Simpson LL. Indications for fetal eehocardiography from a tertiary-care obstetricsonography practice[J]. J Clin Ultrasuond, 2004, 32(3): 123-128.
[19]
Apostolopoulou SC, Manginas A, Cokkinos DV, et al. Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease[J]. Heart, 2005, 91(11): 1447-1452.
[20]
Mahle WT, Martin GR, Beekman RH, et al. Endorsement of health and human services recommendation for pulse oximetry screening for critical congenital heart disease[J]. Pediatrics, 2012, 129(1): 190-192.
[21]
Mahle WT, Newburger JW, Matherne GP, et al. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics[J]. Circulation, 2009, 120(5): 447-458.
Duppenthaler A, Ammann RA, Gorgievski-Hrisoho M, et al. Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease[J]. Arch Dis Child, 2004, 89(10): 961-965.
[24]
Goyal P, Kiran U, Chauhan S, et al. Efficacy of nitroglycerin inhalation in reducing pulmonary arterial hypertension in children with congenital heart disease[J]. Br J Anaesth, 2006, 97(2): 208-214.
